MicroRNA miR-106a-5p targets forkhead box transcription factor FOXC1 to suppress the cell proliferation, migration, and invasion of ectopic endometrial stromal cells via the PI3K/Akt/mTOR signaling pathway
article
OA: gold
CC0
⤵ 12 in-corpus citations
AI-generated summary
MiR-106a-5p directly targets FOXC1, suppressing ectopic endometrial stromal cell proliferation, migration, and invasion by inhibiting the PI3K/Akt/mTOR pathway.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Emerging evidence has exhibited an obvious decreased expression of miR-106a-5p in the ectopic endometrial tissue of endometriosis (EMS) patients. Thus far, the pathophysiological function of miR-106a-5p in EMS is unknown. A previous study showed an increased FOXC1 expression in the ectopic endometrial tissue of patients with EMS. Moreover, we found that there was a binding site of miR-106a-5p on the 3'UTR of FOXC1 through bioinformatics predictions. Hence, we speculated that miR-106a-5p might affect the development of EMS via targeting FOXC1. We first showed a decreased level of miR-106a-5p and an increased level of FOXC1 mRNA in ectopic endometrial tissues compared with normal tissues. Functionally, we transfected ectopic endometrial stromal cells (ESCs) with miR-106a-5p mimics or NC mimics and indicated an inhibitory role of miR-106a-5p on ESC proliferation, invasion, and migration. Mechanistically, FOXC1 was found to be a target gene of miR-106a-5p. To confirm whether miR-106a-5p exerted an inhibitory activity in ESCs via targeting FOXC1, miR-106a-5p mimic was co-transfected into ESCs with the FOXC1-plasmid or vector. We found that FOXC1 overexpression evidently reversed the results caused by a miR-106a-5p mimic in ESCs. Additionally, our results demonstrated that miR-106a-5p mimic inhibited the expression of p-Akt and p-PI3K. Collectively, these results revealed that miR-106a-5p inhibited the proliferative, migratory, and invasive ability of ESCs via directly binding to FOXC1, likely through the suppression of the PI3K and its downstream signaling pathway, which offered a potential and novel therapeutic strategy for EMS treatment.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (52)
- Clinical Management of Endometriosis via openalex
- Clinical Management of Endometriosis via openalex
- Curcumin delays endometriosis development by inhibiting MMP-2 activity. via openalex
- Diagnosis and management of endometriosis. via openalex
- Effect of vascular endothelial growth factor and interleukin-1β on apoptosis in endometrial cell cultures from patients with endometriosis and controls via openalex
- Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Endometriosis still a challenge. via openalex
- Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis via openalex
- Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis via openalex
- Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
- MicroRNAs in endometriosis: biological function and emerging biomarker candidates† via openalex
- miR-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12 via openalex
- miR-200c suppresses endometriosis by targeting MALAT1 in vitro and in vivo via openalex
- Overexpression of microRNA‐542‐3p attenuates the differentiating capacity of endometriotic stromal cells via openalex
- PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage via openalex
- Regulation of miR-33b on endometriosis and expression of related factors. via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Role of lncRNA FTX in invasion, metastasis, and epithelial-mesenchymal transition of endometrial stromal cells caused by endometriosis by regulating the PI3K/Akt signaling pathway via openalex
- Role of melatonin in regulating matrix metalloproteinase‐9 via tissue inhibitors of metalloproteinase‐1 during protection against endometriosis via openalex
- Silencing of cofilin-1 gene attenuates biological behaviours of stromal cells derived from eutopic endometria of women with endometriosis via openalex
- The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis via openalex
- The role of the peritoneum in the pathogenesis of endometriosis via openalex
- The shifting landscape of genetic alterations separating endometriosis and ovarian endometrioid carcinoma. via openalex
- Up-regulation of Bcl-2 by CD147 Through ERK Activation Results in Abnormal Cell Survival in Human Endometriosis via openalex
- Uterus-like mass in the uterine cervix: superficial cervical endometriosis with florid smooth muscle metaplasia? via openalex
- W2767201918 via openalex
- W2146510550 via openalex
- W2792941586 via openalex
- W2803918435 via openalex
- W2810470954 via openalex
- W2092324058 via openalex
- W2888829515 via openalex
- W2900597665 via openalex
- W2912936715 via openalex
- W1984483611 via openalex
- W2978560093 via openalex
- W2981080119 via openalex
- W1974645069 via openalex
- W1969415039 via openalex
- W3028783850 via openalex
- W3133671115 via openalex
- W3157251856 via openalex
- W1000251227 via openalex
- W6608139517 via openalex
- W6635732373 via openalex
- W2151001058 via openalex
- W2468004912 via openalex
- W2510638715 via openalex
- W2525370412 via openalex
- W2596882124 via openalex
- W2751010315 via openalex
Cited by (12)
- Evidence for KISS-1 nuclear translocation and PI3K/AKT signaling in the ultrastructurally and morphometrically analyzed human endometriosis 2026
- Integrated bioinformatics analysis and machine learning identifies FZD4, SRPX2, and COL8A1 as angiogenesis hub genes in endometriosis 2025
- Mechanism of FOXC1 in the invasion and migration of ectopic endometrial stromal cells in endometriosis 2025
- Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin 2025
- Prognostic Value and Immune Relevancy of a Combined Necrosis-Related Gene Signature in Endometriosis 2024
- Additional file 2 of Signatures of necroptosis-related genes as diagnostic markers of endometriosis and their correlation with immune infiltration 2024
- Additional file 2 of Signatures of necroptosis-related genes as diagnostic markers of endometriosis and their correlation with immune infiltration 2024
- Focusing on the role of protein kinase mTOR in endometrial physiology and pathology: insights for therapeutic interventions 2024
- Signatures of necroptosis-related genes as diagnostic markers of endometriosis and their correlation with immune infiltration 2023
- Research advances in endometriosis-related signaling pathways: A review 2023
- Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis 2023
- The Role of mTOR and eIF Signaling in Benign Endometrial Diseases 2022
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:37.768885+00:00
License: CC0
· commercial use OK